IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATIO

Phase 4

Recruiting

• Conditions: Kidney Transplantation; Renal insufficiency; 10029149

• Registration Number: NL-OMON36311
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 194

Inclusion Criteria

Adult patients (18 years or older) who have received an ABO-compatible single-organ kidney transplant from a living donor and who are on the immunusuppressive regimen of: tacrolimus, mycophenolate mofetil and prednisolon.

Exclusion Criteria

Patients need to be on immunosuppressive therapy with tacrolimus, prednisolon and mycophenolate mofetil at 3 months after transplantation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified